Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy

被引:24
作者
Abrahamson, Martin J. [1 ]
Peters, Anne [2 ]
机构
[1] Harvard Univ, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
[2] Univ So Calif, Keck Sch Med, Div Endocrinol, Los Angeles, CA 90033 USA
关键词
Basal-bolus; insulin; intensification; type 2 diabetes mellitus; RAPID-ACTING INSULIN; TO-TARGET TRIAL; QUALITY-OF-LIFE; CONSENSUS STATEMENT; GLYCEMIC CONTROL; EUROPEAN-ASSOCIATION; MEDICAL-MANAGEMENT; INITIATING INSULIN; MEALTIME TREATMENT; ORAL-AGENTS;
D O I
10.3109/07853890.2012.699715
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of diabetes mellitus is projected to continue to increase worldwide over the next 20 years leading to increased costs in the management of the disease and its associated co-morbidities. Insulin replacement is one of many treatment options that can help to bring about near normoglycemia in the patient with type 2 diabetes mellitus (T2DM). Glycemic control as close to normoglycemia as possible can help to reduce the risk of microvascular and macrovascular complications, yet less than one-half of patients with T2DM achieve glycemic targets as recommended by practice guidelines. The purpose of this review is to provide guidance to primary care physicians for the initiation and intensification of basal-bolus insulin therapy in patients with T2DM. Two treatment algorithms that can be both patient- and physician-driven are proposed: a stepwise approach and a multiple daily injections approach. Evidence shaping the two approaches will be discussed alongside management issues that surround the patient treated with insulin: hypoglycemia, weight gain, patient education, and quality of life.
引用
收藏
页码:836 / 846
页数:11
相关论文
共 59 条
  • [1] Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey
    Akram, Kamran
    Pedersen-Bjergaard, Ulnik
    Borch-Johnsen, Knut
    Thorsteinsson, Birger
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (06) : 402 - 408
  • [2] Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus
    Anderson, JH
    Brunelle, RL
    Keohane, P
    Koivisto, VA
    Trautmann, ME
    Vignati, L
    DiMarchi, R
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) : 1249 - 1255
  • [3] Improved mealtime treatment of diabetes mellitus using an insulin analogue
    Anderson, JH
    Brunelle, RL
    Koivisto, VA
    Trautmann, ME
    Vignati, L
    DiMarchi, R
    Cameron, DP
    Yeu, DK
    Zimmet, P
    Lauvaux, JP
    VanGaal, LF
    Chiasson, JL
    Fettes, IM
    Tan, MH
    Toth, EL
    Charbonnel, B
    Selam, JL
    Haslbeck, M
    SchulzeSchleppinghoff, B
    Karasik, A
    Hazenberg, HJ
    VanDoorn, LG
    Bonnici, FB
    Hough, S
    Mollentze, WF
    Moore, R
    Omar, MA
    Robertson, LI
    VanRooyen, RJ
    DeLeiva, A
    Jara, A
    Vazquez, JA
    Arslanian, S
    Bastyr, EJ
    Bergenstal, RM
    Blonde, L
    Boyce, PA
    Chase, HP
    Clarke, DH
    Davidson, J
    Garber, A
    Goldberg, RB
    Guthrie, RA
    Mayfield, RK
    Mengel, MC
    Prince, MJ
    Reeves, ML
    Rosenzweig, JL
    Schade, DS
    Soeldner, JS
    [J]. CLINICAL THERAPEUTICS, 1997, 19 (01) : 62 - 72
  • [4] [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004]
  • [5] [Anonymous], NEW ENGL J MED
  • [6] [Anonymous], DIAB BACKGR
  • [7] [Anonymous], MEDSCAPE DIABETES EN
  • [8] [Anonymous], CTR DIS CONTR DET DA
  • [9] [Anonymous], AM DIAB ASS 69 SCI S
  • [10] [Anonymous], MAN TYP 2 DIAB